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ABSTRACT Circulating leukocyte sequestration in pulmonary capillaries is arguably the initiating event of lung injury in acute
respiratory distress syndrome. We present a microﬂuidic investigation of the roles of actin organization and myosin II activity
during the different stages of leukocyte trafﬁcking through narrow capillaries (entry, transit and shape relaxation) using speciﬁc
drugs (latrunculin A, jasplakinolide, and blebbistatin). The deformation rate during entry reveals that cell stiffness depends
strongly on F-actin organization and hardly on myosin II activity, supporting a microﬁlament role in leukocyte sequestration. In
the transit stage, cell friction is inﬂuenced by stiffness, demonstrating that the actin network is not completely broken after a forced
entry into a capillary. Conversely, membrane unfolding was independent of leukocyte stiffness. The surface area of sequestered
leukocytes increased by up to 160% in the absence of myosin II activity, showing the major role of molecular motors in microvilli
wrinkling and zipping. Finally, cell shape relaxation was largely independent of both actin organization and myosin II activity,
whereas a deformed state was required for normal trafﬁcking through capillary segments.
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The mechanical plugging of lung microvessels by leukocytes
has been implicated in the pathophysiology of several
diseases, such as acute lung injury (ALI). The estimated
190,000 cases of ALI in the United States generate high
costs, and acute respiratory distress syndrome (ARDS), the
most hypoxemic ALI presentation, results in a mortality
rate ranging from 34% to 58% (1). ARDS is a challenging
entity for clinical investigation because it lacks an accepted
diagnostic test and relies on a panel of clinical findings for
diagnosis. Leukocyte sequestration has been reported after
sepsis, trauma, hemorrhagic shock, or ischemia (2), and
sequestration in lung microvasculature is considered as the
initiating event in the development of ARDS (3).
It is difficult to study the mechanisms of leukocyte seques-
tration (adhesion and/or low deformability) in humans.
Recent evidence demonstrates that the initial stages of
neutrophil sequestration in rats are not due to CD11-CD18
mediated adhesion, supporting a major involvement of
leukocyte mechanical properties in sequestration (4). Also,
leukocyte mechanical behavior was investigated with the
use of many techniques aimed at quantifying leukocyte de-
formability and rheology under various conditions, including
cell poker (5), polycarbonate filter (6), parallel plates (7),
atomic force microscopy (8), optical tweezers (9), microrhe-
ometry, and micropipette aspiration (10). Although power
law rheology behavior and associated models are gaining
ground (11,12), there is no universal understanding of the
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0006-3495/09/05/4308/11 $2.00precise role of the three major filamentous constituents of
the cytoskeleton—microtubules (10), intermediate filaments
(13), and actin filaments (14)—in leukocyte mechanical
properties. Actin filaments appear to be a primary structural
determinant of neutrophil mechanical properties (14).
Furthermore, Nishino and co-workers (15) demonstrated
that neutrophils from patients with septic shock and ARDS
were significantly more rigid than controls, and observed
a change in actin network polymerization. Evidence for the
formation of an actin-rich rim in the submembrane region
of deformed (16) and ARDS patient (15) leukocytes raises
questions regarding the precise role of actin microfilament
organization in the mechanical changes of circulating leuko-
cytes (17). On the other hand, La¨mmermann and co-workers
(18) recently demonstrated that myosin II-dependent
contraction of migrating leukocytes was required for passage
through narrow gaps, suggesting an important contribution
of molecular motors in the behavior of leukocytes seques-
tered in narrow capillaries. These results underline the
importance of investigating the precise roles of actin and
actomyosin activity in capillary leukocyte trafficking.
Significant insights into the rheological properties of
model leukocytes in microcapillaries, such as HL60 or
THP-1 cells, have been obtained by micropipette aspiration,
but only in the first stage of leukocyte entry into constriction.
Additional information on subsequent stages (capillary
transit and shape recovery) under physiologically relevant
hydrodynamical conditions is needed. The versatility of mi-
crofluidics allows physiologically relevant testing on the
whole passage process (16,19) and may be more relevant
to clinical problems.
Here, we present an efficient microfluidic approach to
measure new relevant parameters of leukocyte transit in
narrow capillaries, such as entry time (ET), cell velocity in
doi: 10.1016/j.bpj.2009.02.037
Cell Trafﬁc in Microﬂuidic Capillary 4309FIGURE 1 Microfluidic setup. (A) Pressure drops were
imposed by varying the height of water, DH, between the
upstream and downstream macroreservoirs. Cells were
introduced into the device by a syringe connected to the
upstream reservoir with a three-way valve. The inset shows
a picture of the 4-mm-wide constriction channel (length:
2250 mm) and 20-mm-wide inlet/oulet channels. Scale bar
corresponds to 850 mm. (B) Maximum fluid velocity
measured by fluorescent particles tracking, MxFV, versus
DH. Values are mean  SE; n ¼ 4.constriction, cell morphology during capillary transit
through a constriction, shape recovery kinetics after passage,
and the effect of a first deformation on the passage through
successive segments. We intend to define the specific role
of actin cytoskeleton and actomyosin activity in the passage
of circulating leukocytes through narrow capillaries. To that
end, we specifically enhanced or inhibited actin cytoskeleton
and actomyosin activity. We used actin-specific agents with
well-described molecular effects: latrunculin A (LatA),
a potent microfilament inhibitor (20); jasplakinolide (Jpk),
which stabilizes actin filaments (21); and blebbistatin
(Blb), which specifically inhibits myosin II activity in leuko-
cytes (22). We confirm the important influence of actin fila-
ment organization on the deformation rate in the entry stage.
Our results also provide what we believe are new insights
into the roles of actin cytoskeleton and myosin II activity
during the transit stage. Cell velocity in the constriction is
lower because the actin network is more organized, and
cell membrane unfolding is controlled by myosin II activity.
In the relaxation stage after release from the constriction, we
found that actin organization and molecular motor activity
did not influence the shape recovery process, and that a
deformed shape helps normal trafficking through successive
capillary segments.
MATERIALS AND METHODS
Cell preparation and drug treatments
We used the monocytic THP-1 line (23) maintained as previously described
(24) in Roswell Park Memorial Institute-1640 medium (Invitrogen, Cergy
Pontoise, France) supplemented with 20 mM HEPES buffer, 10% fetal
calf serum (FCS), 2 mM L-glutamine, 50 U/mL penicillin, and 50 mg/mL
streptomycin. Stock cell cultures were passaged twice weekly and main-
tained at 37C in a humidified atmosphere containing 5% CO2. Cell diam-
eter was determined by cytometry at a mean of 12.5 mm with a standard
deviation (SD) of 0.75 mm. Jpk (J7473, 1.4 mM; Molecular Probes, Eugene,
OR), LatA (L12370, 2.37 mM; Molecular Probes, Eugene, OR), and Blb
(75 mM; Fischer Bioblock Scientific, Illkirch, France) stock solutions
were prepared in dimethyl sulfoxide (DMSO) and stored at 20C. Cells
(1  106/mL) were incubated at 37C with Jpk, LatA, and Blb at concentra-
tions of 3, 3, and 50 mg/mL, respectively, on a rocking platform for 20 min
for Blb (25) and 30 min for Jpk and LatA (26). Control experiments showed
that DMSO up to 0.5% does not affect THP-1 mechanical properties, and
additional experiments performed 30 min after the exposition period demon-
strated that the effects of these drugs were sustained for the entire experi-
mental period.Microﬂuidic setup
Microfluidic channels were drawn using Clewin software (WieWeb Soft-
ware, Hengelo, TheNetherlands) and a chromiummask (Toppan Photomask,
Corbeil Essonnes, France) was then generated. Using standard soft lithog-
raphy procedures (27), a master of channels was fabricated on a silicon wafer
by photolithography with photosensitive resins (SU-8 2015; Microchem,
Newton, MA) and microfluidic channels were molded with polydimethylsi-
loxane (PDMS, Sylgard 184 Silicone Elastomer Kit; DowCorning,Midland,
MI). Ports to plug the inlet and outlet reservoirs were punched in the PDMS
replica with a gauge needle. The device was finalized by sealing the PDMS
piece on 170-mm-thick glass coverslips via O2-plasma activation of both
surfaces, and all channels were incubated with a 1% pluronic F108 solution
(BASF,Mount Olive, NJ) for 2 h to deter cell adhesion. Inlet and outlet reser-
voirs were connected to the microfluidic device with Teflon tubings and the
reservoirs were attached to a linear translation stagemounted on a linear slide.
Pressure drops across the microchannel were controlled by varying the height
between inlet and outlet macroreservoirs (Fig. 1 A). Observations were made
with an inverted microscope (Olympus IX71) equipped with an oil objective
of magnification 100 (UplanFLN 1.30; Olympus, Tokyo, Japan).
Our device is composed of an inlet channel, a 4-mm-wide constriction
channel, and a relaxation channel (Fig. 1 A). All channels have the same
heightH of 16 mm, and all experiments were performed with cells of selected
diameter Di ¼ 12  0.5 mm. Geometrically, a spherical cell of diameter Di
squeezed at constant volume in a slit of width W is deformed into a puck of
height W and diameter Dpu:
Dpu ¼
ﬃﬃﬃﬃﬃﬃﬃﬃ
2D3i
3W
r
: (1)
In our experiments, Di ¼ 12 mm and W ¼ 4 mm (Eq. 1) give Dpu ¼ 17 mm.
Given that H ¼ 16 mm, undeformed cells travel freely in the inlet and relax-
ation channels, and squeezed cells in the constriction at minimum deforma-
tion fill the full cross-section area of the constriction. The latter condition
ensures that the pressure drop across the constriction applies fully to cells
with minimum fluid leakage around them.
RESULTS
Microﬂuidic experiments
A typical experiment consists of video-recording the
different stages of a single cell crossing the 4-mm-wide
constriction, i.e., entry, transit, and shape recovery after
release (see Movie S1 in the Supporting Material). The
constraint applied to the cells corresponds to physiological
flow conditions maintained by applying constant hydrostatic
pressure. A calibration was performed by tracking fluores-
cent micron-size particles in the constriction to measure the
maximum fluid velocity, MxFV, against the applied pressureBiophysical Journal 96(10) 4308–4318
4310 Gabriele et al.FIGURE 2 Entry stage. (A) Image sequence of a Blb-treated THP-1 cell during entry into the 4-mm-wide constriction (DH¼ 10.8 cm H2O); (a) approach, (b)
contact, (c), (d and e) development of a projection in the constriction, and (f) completed entry. The scale bar represents 12 mm. (B) ETs versus height of water,
DH, for normal (), Blb-treated (>), Jpk-treated (6), and LatA-treated (7) THP-1 cells. Error bars represent SE (THP-1: n¼ 7; LatA: n¼ 4; Jpk: n¼ 4; Blb:
n ¼ 6).DH between the inlet and outlet reservoirs (Fig. 1 B). The
local pressure drop across the constriction is 10-fold smaller
than DH.
Cell ETs are dependent on actin cytoskeleton
organization
Fig. 2 A shows a typical sequence of the deformation displayed
by a THP-1 cell entering the narrow capillary. The cell projec-
tion length versus the time in the constriction entry stage
follows a sigmoidal curve (Fig. S1). Cell deformability can
also be assessed by measuring the time required for cells to
enter the constriction. We defined the ET as the time interval
between the leading edge of the cell crossing the entry into
the microchannel and its trailing edge clearing the entry. Serial
single-cell ET measurements as a function of applied driving
pressures (Fig. 2 B) were taken 30 min after exposure to Jpk
and LatA. Generally, the ET decreases with driving pressure
and the dependency of ET on cell treatments is enhanced at
low driving pressures. Jpk-treated cells exhibited very long
ETs of >700 s at low DH (6 cm H2O), ~3-fold higher than
controls.Conversely, the averageETat lowDHofLatA-treated
cells was ~2 times lower than the ETs of controls. Further, the
ETs observed for Blb-treated cells exhibited only minor differ-
ences from controls. Thus, the ETs of cells in a narrowcapillary
are affected mainly by the passive actin cytoskeleton organiza-
tion and marginally by molecular motor activity.
Cell velocity in constriction depends on the actin
cytoskeleton
The cell velocity was constant all along the 2250-mm-long
constriction. The mean cell velocity, MnCV, was determinedBiophysical Journal 96(10) 4308–4318using the time interval between the trailing edge of the cell
clearing the entry and its leading edge clearing the constric-
tion. The mean fluid velocity, MnFV, was calculated using
the measured maximum velocity MxFV and the theoretical
flow profile in our microchannels (28). Fig. 3 A shows the
evolution of MnCV/MnFV ratios as a function of the applied
driving pressure. For control and treated cells, MnCV/MnFV
ratios are significantly smaller than one at low driving pres-
sures and increase roughly toward one with increasing
driving pressures. Lat-A treated cells are characterized by
a high MnCV/MnFV (~0.7) at the lowest applied driving
pressure as compared to control cells (MnCV/
MnFV~0.35), whereas Jpk-treated cells have the lowest
MnCV/MnFV (~0.1). Clearly, our microfluidic setup allows
us to gain insight into the different degrees of resistance to
cell transit in the capillary. Also, the MnCV/MnFV ratios
of Blb-treated cells were very similar to control cells for
all pressure drops. These results suggest that friction between
circulating leukocytes and capillary walls is hardly influ-
enced by myosin activity and is strongly dependent on actin
cytoskeleton organization.
Myosin II activity controls the sequestered cell
membrane unfolding
To obtain further insight into the sequestered cell
morphology, we monitored the maximum axial length, Lm,
of the cells in the constriction. No significant evolution of
Lm was observed during the cell transit, suggesting that Lm
depends only on the cell entry process. As a morphological
reference, we used the puck diameter Dpu ¼ 17 mm corre-
sponding to a cell of initial diameter Di ¼ 12 mm squeezed
Cell Trafﬁc in Microﬂuidic Capillary 4311FIGURE 3 Transit stage. (A) MnCV/MnFV and (B) Lm/Dpu as a function of the height of water, DH, for normal (), Blb-treated (>), Jpk-treated (6), and
LatA-treated (7) THP-1 cells. (C) Microscope pictures of THP-1 cells before entry into the constriction (a and b), in the constriction (c and d), and shortly after
their release from the constriction when the free-rotating cell presented a maximum size (e and f). Pictures c and d give respectively insight into the top- and
side-views of the cell in the constriction. Case I: Control and Jpk- and Lat-A-treated cells have a puck shape with diameter ¼ 17 mm, height W ¼ 4 mm, and
excess surface area DS/S¼ 50% for all DH (left cartoon). Case II: Blb-treated cells have a roughly parallelepipedic shape with dimensions of 4, 16, and 29 mm,
and excess surface area DS/S ¼ 160% at DH ¼ 10.8 cm H2O (right cartoon). Scale bars on pictures represent 10 mm.between parallel walls distant of W ¼ 4 mm (see Materials
and Methods section). Two different trends can be distin-
guished on Fig. 3 B. The first behavior corresponds to
control, Jpk-treated, and Lat-A-treated cells, for which Lm/Dpu
is always close to one. The second behavior corresponds to
Blb-treated cells, for which Lm/Dpu is always >1 and rea-
ches a maximal value of 1.7 at the lowest applied driving
pressure. This finding suggests that only Blb-treated cellsexceed the minimal deformation into a puck of diameter
Dpu and height W. To determine the exact morphology of
confined cells, we need to get access to a side view of the
cell. This side view can be obtained in the relaxation channel,
where released cells rotate freely, allowing access to new
angles of sight on the deformed cells (Movie S2). A good
approximation of a side view of a confined cell was obtained
from the image of the released cell corresponding toBiophysical Journal 96(10) 4308–4318
4312 Gabriele et al.a maximum area. The delay after release of the side-view
pictures (~1 s) was short compared to the shape recovery
time (~50 s), ensuring that the cell morphology was still
close to the morphology in the constriction. Fig. 3 C shows
sequences of three microscopic pictures for cells 1), in the
inlet channel (pictures a and b); 2), in the constriction
FIGURE 4 Shape relaxation stage. (A) Image sequence of a THP-1 cell at
different times after release from a 4-mm-wide constriction (a) t ¼ 0.6 s, (b)
t ¼ 7.2 s, (c) t ¼ 26 s, (d) t ¼ 41.7 s, (e) t ¼ 204.3 s, and (f) t ¼ 413.5 s. The
scale bar represents 8 mm. (B) Long/short-axis ratio (l/s) of a THP-1 cell
versus the time after release from a 4-mm-wide constriction. Error bars repre-
sent SE (THP-1 (): n ¼ 4, LatA (7): n ¼ 3, Jpk (6): n ¼ 4, Blb (>):
n ¼ 3). The+ sign at t ¼ 0 corresponds to the theoretical l/s ratio of a puck
with diameter 16.8 mm and height W ¼ 4 mm. The inset shows long (l) and
short (s) axes on a picture of a deformed cell. (C) Series of images showing
the passage of a single THP-1 cell through a succession of 5-mm-wide
segments. Scale bar represents 15 mm.Biophysical Journal 96(10) 4308–4318channel (pictures c and d); and 3), in the relaxation channel
shortly after release (pictures e and f). These images corre-
spond respectively to the undeformed spherical cell, the
top view, and the side view of the sequestered cell. The
morphologies observed for normal and Jpk- and LatA-
treated cells (Fig. 3 C, case I) are all similar and correspond
well to a puck of diameter Dpu and width W, i.e., to the
minimal geometric deformation required for a sphere to enter
our microfluidic constriction. The ratio between the cell
surface in the puck shape, Spu, and in the initial spherical
shape, Si, can be determined using Eq. 2:
Spu=Si ¼ Di
3W
þ
ﬃﬃﬃﬃﬃﬃﬃ
2W
3Di
r
: (2)
Spu/Si is ~1.5, which corresponds to an excess of cell
membrane surface of 50% in the deformed state of case I.
On the other hand, the image sequence of case II in Fig. 3 C
is typical of a Blb-treated cell in the constriction at a low
applied driving pressure (13.7 cm H2O). The cell mor-
phology in the constriction corresponds roughly to a
parallelepiped with rounded edges of dimensions 4, 16, and
29 mm. The cross-section dimension 4  16 mm of the
deformed cell matches the cross-section W  H of the
constriction because the cell expansion is obviously frus-
trated in directions perpendicular to the constriction main
axis. The ratio between the cell surface in its parallelepipedic
shape, Spa, and its initial spherical shape, Si, is expressed by
Eq. 3:
Spa=Si ¼ 2

HW þ WLm þ HLm
pD2i

: (3)
Spa/Si is ~2.6, which corresponds to an excess of cell
membrane surface of 160% in the deformed state for the cells
of case II in Fig. 3 B. These data suggest that, at low applied
pressures, inhibition of molecular motors induces a large cell
surface increase as compared with the minimal surface
increase required to enter the constriction.
Actin organization and actomyosin activity
do not inﬂuence the shape recovery process
After the cells crossed the 4-mm-wide constriction, they were
released into a 20-mm-wide channel, which allowed us to
observe the shape relaxation free of external constraints
(Fig. 4 A). We studied the kinetics of shape recovery quanti-
tatively by monitoring the long/short-axis ratio (l/s; inset of
Fig. 4 B). Since the cell can rotate in the relaxation channel,
one must take care to select only pictures corresponding to
the same angle of view. The temporal evolution of l/s is pre-
sented in Fig. 4 B for control and treated cells. The effect of
F-actin stabilization (with Jpk), actin disruption (with LatA),
or myosin II activity inhibition (with Blb) does not affect the
dynamics of leukocyte shape recovery as compared with the
unstimulated control groups (THP-1). Furthermore, the
Cell Trafﬁc in Microﬂuidic Capillary 4313shape is characterized by a fast relaxation (~50 s) of l/s down
to 1.3 (which corresponds to the image of Fig. 4 Ad) for
control and Jpk-, LatA-, and Blb-treated cells (Fig. 4 B).
Transit through successive capillary segments
In vivo, leukocytes cross between 50 and 100 segments in
a single passage through the highly interconnected pulmo-
nary microvasculature (29). To approach physiological
geometries, a long, single capillary was exchanged for
a succession of short, narrow segments of width 5 mm and
length 20 mm (30). A typical sequence of transit through
these segments is presented in Fig. 4 C (see Movie S3).
The ET is ~25 s in the first constriction and 0.5 s in all sub-
sequent constrictions. This illustrates that a deformed shape
(l/s ~ 1.5) facilitates leukocyte transit through the capillary
network.
DISCUSSION
Accumulation of leukocytes in pulmonary microvessels (31)
is implicated in the pathophysiology of a number of diseases.
However, the direct study of leukocyte retention in human
microvasculature is a difficult task. Several micromanipula-
tion techniques have enabled the mechanical behavior of
nonadherent cells to be studied in vitro. Micropipette aspira-
tion permits investigators to mimic cell deformation in the
capillary entry stage, but not to study other stages of cell
passage, such as transit dynamics. Polycarbonate filter exper-
iments allow researchers to quantify cell transit times
through narrow pores, but not to observe cells in the pores.
Our microfluidic experiments allowed us to study and
observe at the single-cell level the entry, transit, and shape
relaxation stages of leukocyte passage in a constriction.
Our 4-mm-wide constrictions aim to mimic human pulmo-
nary capillaries, whose radii vary from 1 to 7.5 mm, with
a mean of 3.7 mm (32). Our setup also mimics physiological
flow conditions by maintaining constant hydrostatic pressure
over time (33).
Previous studies have raised questions regarding the
precise role of actin organization and molecular motor
activity in the mechanical behavior of leukocytes during
their passage in the microvasculature. Actin filaments are
a primary structural determinant of cell mechanical proper-
ties (14), and leukocytes from patients with sepsis shock
and ARDS are abnormally rigid and exhibit an actin-
enriched rim in the submembrane region (15,34). On the
other hand, myosin II activity plays a role in the mechanical
properties of eukaryotic cells (35–37), in the passage of
leukocytes through narrow gaps via squeezing contractions
during transmigration (18), and in the blebbing motility of
leukocytes confined in two or three dimensions (38). There-
fore, in this work we investigated the role of actin organiza-
tion and myosin II activity in the passage of cells through
a microfluidic capillary by exposing the cells to specificinhibitors of actin polymerization/depolymerization (LatA
and Jpk) and myosin II activity (Blb).
Passive actin cytoskeleton reorganization
controls capillary entry
The projection length Lm versus the time in the constriction
entry stage follows a sigmoidal curve, which is consistent
with investigations of leukocyte deformation with micropi-
pette aspiration (10). This validates the microfluidic
approach as an efficient technique to study the mechanical
behavior of circulating cells. A key observation is that spher-
ical leukocytes need a finite time to deform and enter the
constriction. The presence of the nucleus may a priori
contribute to the lack of deformability of leukocytes, espe-
cially in the case of our monocytic cell line THP-1, because
the constriction width is close to the mean diameter of
a monocytic nucleus (39). However, the results observed
with LatA-treated cells demonstrate that leukocytes with
disrupted microfilaments enter the constriction in very short
times (Fig. 2 B), even at low applied driving forces. This
indicates that the mechanical behavior of leukocytes in our
4-mm-wide constrictions is independent of the viscoelastic
nucleus. Moreover, our results show that large deformations
are facilitated by disruption of actin filament organization,
and that the retardation of cell transit increases with actin
polymerization. Leukocytes must reorganize their actin cyto-
skeleton to enter into microcapillaries. On the other hand, our
data obtained from Blb-treated leukocytes, for which
ATPase activity was reduced to 5% of the initial value
(22), indicate that a drastic reduction of actomyosin activity
reduces the ET only slightly. This is consistent with the
slight decrease of actin cytoskeleton stiffness reported by
Martens and Radmacher (37) on myosin II-inhibited fibro-
blasts. However, the contribution of myosin II for the cell
entry stage is certainly weak in comparison with the large
importance of actin microfilament organization. This
confirms the conclusion of Yap and Kamm (16) that the
ET behaves in a manner consistent with a passive cell.
Actin cytoskeleton controls pressure and friction
with capillary walls
Previous studies of cell transit in capillaries reported that the
strength of the pressure-drop force Fp pushing the cells
through the capillary dominated the friction force Ff resulting
from hydrodynamic forces between the cell and the capillary
walls (16,29). Our microfluidic experiments were designed
to access flow conditions in which the relative strength of
Ff against Fp is high enough to observe deviations of cell
velocities from mean fluid velocity. Our results can be
compared with those obtained by Shao and Hochmuth (40)
in a study focusing on flow resistance of leukocytes in glass
micropipettes. In the absence of nonspecific adhesion
(checked in our experiments on static settled cells), thereBiophysical Journal 96(10) 4308–4318
4314 Gabriele et al.are no physical contacts between the moving cells and the
channel walls, and thus friction is due only to shear stress
in the lubrication film between the cell and the walls.
In vivo, the gap between a trafficking cell and the endothe-
lium is composed of two layers. Close to the wall, the endo-
thelial glycocalyx layer has a thickness of ~500 nm (41).
Between the glycocalyx and the trafficking cell, the lubrica-
tion layer of thickness 15–100 nm (40) contains only
medium fluid. The flow of liquid in the glycocalyx layer
was shown to be low as compared with the flow in the lubri-
cation layer (42). Therefore, the fluid velocity gradient and
hydrodynamic shear stress between the cells and walls
in vivo occurs mainly in the lubrication layer. In our exper-
iments with artificial walls, there is a lubrication layer and no
endothelial glycocalyx layer. Nevertheless, since friction
arises mainly from the hydrodynamic shearing in the lubrica-
tion layer, the force Ff is expected to be comparable in vivo
and in our microfabricated channels. Only the effects of gly-
cocalyx layer compliance under stress (41) are not taken into
account in our experiments. For a given cell and capillary
geometry, the dependance of the ratio between the friction
force Ff and the pressure force Fp against the driving pressure
DP is given by
Ff
Fp
f
v
DPd
; (4)
where v is the cell velocity, DP is the applied pressure, and
d is the lubrication film thickness. The velocity v being
proportional to DP (when friction forces are negligible),
and the lubrication layer thickness d varying as a power
law of velocity with an exponent 2/3 (43),
Ff
Fp
epends on
velocity as
Ff
Fp
f
1
v2=3
: (5)
Equation 5 shows that the relative importance of Ff against
Fp decreases with velocity. Friction forces are therefore
negligible at high driving pressures, and cell velocity is
controlled by pressure forces only. This explains why, in
Fig. 3 A, all MnCV/MnFV ratios tend roughly toward one
for high DP. Conversely, at low driving pressures and low
cell velocities, the relative effects of friction are enhanced,
which explains why we observe various behaviors. For
a given channel geometry and applied driving pressure, the
main parameter controlling the strength of Ff is the lubrica-
tion film thickness, d (40). A lower cell velocity can be attrib-
uted to a thinner lubrication layer, and therefore to a higher
pressure exerted by the cell against the walls. Using this
point of view, several pieces of information can be obtained
in the transit stage from the cell velocity differences. First,
Newtonian liquid drops with the same volume, same surface
tension, and different viscosities would experience the same
lubrication conditions and thus would have the same veloc-
ities. Therefore, only the elasticity of the membrane and/orBiophysical Journal 96(10) 4308–4318the cytoplasm can explain transit velocity differences.
Many micropipette investigations have already demonstrated
viscoelastic effects on the leukocyte entry stage in a capillary
(44). We present here the first evidence (to our knowledge)
that viscoelastic effects also play a significant role in leuko-
cyte transit through a narrow capillary. Second, the fact that
Jpk- and LatA-treated cells exert respectively higher and
lower pressures on the walls as compared to normal cells
demonstrates that the cell elastic component exerting a pres-
sure on the walls arises significantly from the actin network
organization. Third, the velocity results provide direct proof
that the rheological state of normal and Jpk- and LatA-
treated cells differs in the constriction for the different treat-
ments. Strong deformation rates or shear stresses are known
to significantly decrease cells’ elastic moduli (16,45). This
effect may also occur in our experiments, but the velocity
results prove that the forced entry of normal and Jpk-treated
cells in narrow constrictions does not completely disrupt
their actin scaffold. On the other hand, we found that myosin
II activity does not significantly influence velocity and fric-
tion. In the end, friction is strongly influenced by actin
network organization and hardly by myosin II activity,
exactly like stiffness. This further supports the idea that stiff-
ness and friction are highly correlated: the membrane of
stiffer cells (Jpk treated > normal > LatA treated cells) is
pushed harder on the walls, and thus the lubrication film is
thinner and friction higher.
Membrane unfolding: myosin II activity
contributes to microvilli zipping
Excess leukocyte plasmamembrane area is stored in folds and
villi (46), and it was recently suggested that wrinkles are stabi-
lized by membrane-cytoskeleton-membrane bonds (47).
During the deformation of a spherical cell, membrane area
is recruited from this reservoir by wrinkles smoothing out,
e.g., during phagocytosis (48) or squeezing in a constriction.
In our experiments, the deformation process occurs during the
entry stage only. Of interest, normal leukocytes in the
constriction exhibit a minimal deformation from a sphere to
a puck. This implies the existence of a mechanism that resists
excess membrane unfolding. Herant et al. (47) observed
a similar resistance to membrane area expansion against
osmotic pressure. They introduced the concept of a ‘‘molec-
ular velcro’’ mechanism that holds wrinkles together and
whose molecular nature remains largely unknown (49). We
have seen that Jpk- andLatA-treated cells behave like controls.
This demonstrates that alteration of actin filaments does not
play a significant role in the resistance to cell membrane
unfolding, at least in the range of stresses applied here.
On the other hand, Blb-treated cells exhibit a large excess
unfolding under similar applied stress. The surface increase
for Blb-treated cells in the 4-mm-wide capillary reached
160%, whereas minimal deformation to enter the constriction
corresponds to 50%. This demonstrates that the mechanism
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Cell Trafﬁc in Microﬂuidic Capillary 4315or resisting membrane unfolding involves myosin II activity.
oreover, the membrane area increase of 160% is compa-
able to the maximum excess area determined by micropi-
ettes experiments (50). This suggests that Blb-treated cells
ave unfolded the totality of their reservoir membrane wrin-
les, and that wrinkle velcro gripping is largely weakened
ith Blb treatment. This raises an important question: Does
he role of myosin II in velcro gripping consist of reinforcing
he static strength or in accelerating the dynamic re-formation
f new links and wrinkles? The exact function of myosins is
ot completely understood, butmyosin II is always associated
ith contractile activity, such as cytokinesis (pinning apart of
dividing cell) or migration (forward translocation of the
ody of a cell). The contractile function suggests that myosin
I may participate in membrane wrinkling by pulling on actin
laments anchored at different points of the membrane.
ollowing this hypothesis, it is interesting to note that not
ll Blb-treated cells exhibit a maximum unfolding. Blb-
reated cells at the highest applied driving pressure exhibit
inimal membrane unfolding (a surface area increase of
0%), exactly like control cells. This proves that wrinkle grips
till exist in Blb-treated leukocytes before application of
mechanical stress/deformation. Since Blb blocks myosin
n an actin-detached state, there are probably other cross-
inkingmolecules, such as talin or ezrin, that maintainwrinkle
ripping (49). It is also important to note that velcro unzipping
akes place at the lowest mechanical stress intensity. This
urther supports the idea that velcro ungripping is not attribut-
ble to a decrease in the static gripping strength, but rather to
dynamic effect. In Fig. 3 B, the onset of Lm/Dpu for Blb-
IGURE 5 Scheme of the actomyosin activity contribution to membrane
olding. (i) Cell membrane after a large expansion. Microvilli are unfolded
nd membrane-cytoskeleton-membrane links are cleaved. (ii) Normal cells:
inks rebuild and myosin II exerts tension (arrows) to rewrinkle the
embrane. (iii) Blb-treated cells: without myosin II tensile activity links
ay re-form, but the membrane is not wrinkled after 30 s.treated cells starts atDH< 20–25 cm/H2O,which corresponds
to ETs of >30 s. This indicates that the characteristic time
required for velcro detachment is ~30 s. More importantly,
this indicates also that the characteristic time required
for wrinkle re-formation is <30 s in Blb-treated cells; other-
wise, the unfolded state could not be seen. This conclusion
strongly suggests that myosin II activity is directly involved
in the dynamic mechanism of wrinkle re-formation, and that
this mechanism is not fast enough in Blb-treated cells to
compensate for the increase in membrane surface. This
confirms the hypothesis that myosin II is involved in the
dynamics of wrinkle re-formation, most probably by exerting
forces between different anchoring points on the membrane
(Fig. 5).
Membrane unfolding has not been investigated in pulmo-
nary diseases implicating leukocyte sequestration. Most
investigators have focused on cell mechanical and adhesive
properties (51). It has been established that the first leuko-
cyte/endothelium contacts are mediated by selectins and
their counterreceptors (52), and that known adhesion mole-
cules (L-selectin, P-selectin, and CD11/CD18) have no
role in the initial sequestration (4,53). Our experiments
confirm that cell stiffness can contribute to initial sequestra-
tion, which supports the notion that adhesion is not required.
On the other hand, we determined a characteristic time for
membrane velcro unzipping of ~30 s, so that arrested cells
in vivo undergo hydrodynamic stresses on a time span
long enough to permit membrane unfolding. Moreover,
cell activation due to deformation (54) and/or local inflam-
mation can further promote membrane unfolding (55), like
the Blb treatment in our experiments. A full understanding
of the biochemical and mechanical events that occur during
sequestration has not emerged yet; however, our results
suggest that membrane unfolding may play an important
role in leukocyte-endothelial cell interactions by mediating
or aggravating the inflammatory processes.
Deformation threshold for leukocyte activation
Cell velocity was found to be constant for all cells during cell
transit in constrictions. Also, the formation of pseudopods
after passage in constrictions was observed in <10% of
assays with normal and LatA- and Jpk-treated cells. The
forced passage in our constrictions is therefore a poor trigger
of cell activation. This is consistent with the proposition by
Yap and Kamm (54) that activation (pseudopod formation)
occurs only above a deformation threshold. If one defines
Sf/Si as the ratio of the final cell surface area Sf over the initial
cell surface area Si, they found that neutrophil activation
occurs for Sf/Si ¼ 1.86 and not for Sf/Si ¼ 1.26. In our exper-
iments, Sf/Si ¼ 1.5 for normal and LatA- and Jpk-treated
cells, and 10% of the cells activated. It makes sense to say
that Sf/Si is below the threshold. Conversely, for Blb-treated
cells, we found that Sf/Si ¼ 2.6, which is clearly above the
threshold. In this case, ~80% of the cells activated.Biophysical Journal 96(10) 4308–4318
4316 Gabriele et al.Actin and actomyosin activity do not drive the cell
shape recovery
When a leukocyte is expelled from a narrow capillary into
a larger channel, it almost recovers its initial spherical shape
in a characteristic time of 50 s, which is in agreement with
previous observations (56). A remarkable result is that the
shape recovery process is unaffected by perturbations of
actin organization or actomyosin activity. Normal and
treated cells undergo a similar shape recovery. Moreover,
this shape recovery is independent of the duration of seques-
tration in the capillary. These results raise a question as to the
origin of the driving force leading to the shape relaxation,
since it cannot be ascribed to actin polymerization or to acto-
myosin activity. On the other hand, it is interesting to recall
that velocity measurements have shown that the viscoelastic
properties of normal and Jpk- and LatA-treated cells were
very different after their forced passage in the constriction.
One can then conclude that the mechanism driving cell shape
relaxation is robust enough to dominate the effect of different
viscoelastic properties of cells with different actin cytoskel-
eton organizations. A mechanism that drives the global cell
shape and applies forces on a scale of several microns
requires the (re)building of a large macromolecular scaffold.
The three major filamentous constituents of the cytoskeleton
are potentially involved in the constitution of this scaffold.
Our results obtained with Jpk- and LatA-treated cells provide
the first piece of evidence, to our knowledge, that actin is not
dominantly involved in cell shape relaxation. Others have
already presented results suggesting that microtubules play
a negligible role in the mechanical properties of circulating
leukocytes (57,58). This leaves intermediate filaments as
the most probable actor in cell shape recovery after deforma-
tion. It is interesting to note that this conclusion is consistent
with recent experiments demonstrating that vimentin inter-
mediate filaments are the main contributors to the stiffness
of circulating lymphocytes (13). Our results strongly suggest
that the specific role of intermediate filaments in the different
stages of leukocyte trafficking in capillaries should be further
investigated (59).
A deformed leukocyte state helps normal
trafﬁcking through the capillary bed
The kinetics of cell relaxation helps to shed light on the
behavior of leukocytes in pulmonary transit, where the
pathway from an arteriole to a venule consists of 50–100
connected constriction segments (29) and the transit time
has been measured in vivo at a median value of 26 s, with
very large deviations (60). The characteristic shape recovery
time of 50 s observed in our experiments is of particular
interest. This time does not allow complete shape recovery
between two successive segments; however, a deformed
shape may facilitate the leukocytes’ transit through subse-
quent restrictions imposed by the capillary bed.Biophysical Journal 96(10) 4308–4318CONCLUSIONS
We used a microfluidic technique to investigate the passage
of leukocytes in a narrow capillary, which is the starting
event of postsepsis or trauma disorders in the lung microvas-
culature. This in vitro and single-cell approach provides an
improved understanding of the role of actin and myosin II
in capillary leukocyte trafficking under physiologically rele-
vant mechanical and hydrodynamical conditions. We have
established that molecular motor activity and the redistribu-
tion of actin filaments have specific and different roles in the
extent and rate of cell deformation and cell membrane un-
folding in the different stages (i.e., the entry stage, transit
stage, and shape recovery stage) of leukocyte trafficking in
a constriction. Leukocyte ET into a capillary, and hydrody-
namic friction with the capillary walls are strongly enhanced
by the degree of actin polymerization. This confirms the
important role of the actin network organization in the
sequestration of leukocytes in capillaries. To our knowledge,
our results also provide the first assessment of the contribu-
tion of myosin II activity to cellular transit in narrow capil-
laries. Myosin II activity only marginally influences the
global cell mechanical properties, but appears to be a key
element in the mechanism of membrane unfolding under
stress. Finally, the cell shape recovery time of 50 s was
shown to significantly help the transit through the capillary
segment network. Of importance, we also showed that the
characteristic time of cell shape recovery is not driven by
actin polymerization or actomyosin activity, which suggests
that the role of intermediate filaments should be systemati-
cally investigated at each stage of traffic through a capillary.
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